Activity of first-line epirubicin and paclitaxel in metastatic breast cancer is independent of type of adjuvant therapy

por Gennari, A, Bruzzi, P, Orlandini, C, Salvadori, B, Donati, S, Landucci, E, Guarneri, V, Rondini, M, Ricci, S, Conte, P
Publicado 2004